Revolution MD, a leader in safe, controlled delivery of high-risk medications like opioids and other controlled substances today announced the issuance of its patent for a groundbreaking global drug ...

A recent study published in Nature Communications showcased a breakthrough in transdermal drug delivery. Scientists have developed an electrically activated patch with biocompatible metallic membranes ...

Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, posing a major challenge to health systems. There are a variety of ...

Gastroretentive drug delivery systems (GRDDS) represent a sophisticated approach to oral medication by extending the retention time of dosage forms in the stomach. This increased residence time can ...

(Nanowerk Spotlight) Precision in drug delivery has long posed a significant challenge to the medical field. Relying on the body’s circulatory system to transport medications often results in ...

This infographic explores the latest drug delivery strategies that can overcome these challenges—from nanotechnology and ...

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

Instead of applying ointment and attaching a bandage, a "smart patch that regulates treatment intensity on its own just by ...

Most drugs in the U.S. are taken orally because these oral dosage forms have a significant systemic effect on the body after being absorbed from different surfaces along the gastrointestinal tract ...

On December 4, AEI’s Brian J. Miller hosted Rep. Larry Buchson (R-IN), Georges C. Benjamin of the American Public Health Association, Brian Fumio Yagi of Johns Hopkins University, and Boris D.

Bombay High Court rules that drug variants not listed in NLEM are exempt from price caps under DPCO 2013, offering relief to pharma firms but raising concerns over regulatory loopholes.